1. Poland A, Knutson JC: 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol 1982, 22:517-554.
2. Whitlock JP, Jr.: Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol 1990, 30:251-277.
3. Pohjanvirta R, Tuomisto J: Short-term toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in laboratory animals: effects, mechanisms, and animal models. Pharmacol Rev 1994, 46:483- 549.
4. Mandal PK: Dioxin: a review of its environmental effects and its aryl hydrocarbon receptor biology. Journal of Comparative Physiology B-Biochemical Systems and Environmental Physiology 2005, 175:221-230.
5. Poland A, Glover E, Kende AS: STEREOSPECIFIC, HIGH AFFINITY BINDING OF 2,3,7,8- TETRACHLORODIBENZO-PARA-DIOXIN BY HEPATIC CYTOSOL - EVIDENCE THAT BINDING SPECIES IS RECEPTOR FOR INDUCTION OF ARYL-HYDROCARBON HYDROXYLASE. Journal of Biological Chemistry 1976, 251:4936- 4946.
6. Schmidt JV, Bradfield CA: Ah receptor signaling pathways. Annual Review of Cell and Developmental Biology 1996, 12:55-89.
7. Hahn ME: The aryl hydrocarbon receptor: A comparative perspective. Comparative Biochemistry and Physiology C-Toxicology & Pharmacology 1998, 121:23-53.
8. Denison MS, Pandini A, Nagy SR, Baldwin EP, Bonati L: Ligand binding and activation of the Ah receptor. Chem Biol Interact 2002, 141:3-24.
9. Denison MS, Nagy SR: Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003, 43:309-334.
10. Abel J, Haarmann-Stemmann T: An introduction to the molecular basics of aryl hydrocarbon receptor biology. Biol Chem 2010, 391:1235-1248.
11. FernandezSalguero PM, Hilbert DM, Rudikoff S, Ward JM, Gonzalez FJ: Aryl-hydrocarbon receptor-deficient mice are resistant to 2,3,7,8-tetrachlorodibenzo-p-dioxin-induced toxicity. Toxicology and Applied Pharmacology 1996, 140:173-179.
12. Mimura J, Yamashita K, Nakamura K, Morita M, Takagi TN, Nakao K, Ema M, Sogawa K, Yasuda M, Katsuki M, et al.: Loss of teratogenic response to 2,3,7,8-tetrachlorodibenzo-p- dioxin (TCDD) in mice lacking the Ah (dioxin) receptor. Genes to Cells 1997, 2:645-654.
13. Shimizu Y, Nakatsuru Y, Ichinose M, Takahashi Y, Kume H, Mimura J, Fujii-Kuriyama Y, Ishikawa T: Benzo[a]pyrene carcinogenicity is lost in mice lacking the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2000, 97:779-782.
14. Mulero-Navarro S, Fernandez-Salguero PM: New Trends in Aryl Hydrocarbon Receptor Biology. Front Cell Dev Biol 2016, 4:45.
15. Wright EJ, De Castro KP, Joshi AD, Elferink CJ: Canonical and non-canonical aryl hydrocarbon receptor signaling pathways. Current Opinion in Toxicology 2017, 2:87-92.
16. Gutierrez-Vazquez C, Quintana FJ: Regulation of the Immune Response by the Aryl Hydrocarbon Receptor. Immunity 2018, 48:19-33.
17. Pernomian L, da Silva CH: Current basis for discovery and development of aryl hydrocarbon receptor antagonists for experimental and therapeutic use in atherosclerosis. Eur J Pharmacol 2015, 764:118-123.
18. Bjeldanes LF, Kim JY, Grose KR, Bartholomew JC, Bradfield CA: Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc Natl Acad Sci U S A 1991, 88:9543-9547.
19. Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA: An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol 2010, 185:3190-3198.
20. Opitz CA, Litzenburger UM, Sahm F, Ott M, Tritschler I, Trump S, Schumacher T, Jestaedt L, Schrenk D, Weller M, et al.: An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 2011, 478:197-203.
21. Liu Y, Liang X, Yin X, Lv J, Tang K, Ma J, Ji T, Zhang H, Dong W, Jin X, et al.: Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-gamma-induced immunologic dormancy of tumor-repopulating cells. Nat Commun 2017, 8:15207.
22. Rannug A, Rannug U, Rosenkranz HS, Winqvist L, Westerholm R, Agurell E, Grafstrom AK: Certain photooxidized derivatives of tryptophan bind with very high affinity to the Ah receptor and are likely to be endogenous signal substances. J Biol Chem 1987, 262:15422- 15427.
23. Wincent E, Amini N, Luecke S, Glatt H, Bergman J, Crescenzi C, Rannug A, Rannug U: The suggested physiologic aryl hydrocarbon receptor activator and cytochrome P4501 substrate 6-formylindolo[3,2-b]carbazole is present in humans. J Biol Chem 2009, 284:2690-2696.
24. Wincent E, Bengtsson J, Mohammadi Bardbori A, Alsberg T, Luecke S, Rannug U, Rannug A: Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc Natl Acad Sci U S A 2012, 109:4479-4484.
25. Casper RF, Quesne M, Rogers IM, Shirota T, Jolivet A, Milgrom E, Savouret JF: Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999, 56:784-790.
26. Ciolino HP, Daschner PJ, Yeh GC: Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 1999, 340 ( Pt 3):715-722.
27. Puppala D, Gairola CG, Swanson HI: Identification of kaempferol as an inhibitor of cigarette smoke-induced activation of the aryl hydrocarbon receptor and cell transformation. Carcinogenesis 2007, 28:639-647.
28. Kim SH, Henry EC, Kim DK, Kim YH, Shin KJ, Han MS, Lee TG, Kang JK, Gasiewicz TA, Ryu SH, et al.: Novel compound 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o- tolylazo-phenyl)-amide (CH-223191) prevents 2,3,7,8-TCDD-induced toxicity by antagonizing the aryl hydrocarbon receptor. Mol Pharmacol 2006, 69:1871-1878.
29. Quintana FJ, Basso AS, Iglesias AH, Korn T, Farez MF, Bettelli E, Caccamo M, Oukka M, Weiner HL: Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
30. Hidaka T, Ogawa E, Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Fujimura T, Aiba S, Nakayama K, Okuyama R, et al.: The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin. Nat Immunol 2017, 18:64-73.
31. Perdew GH: Association of the Ah receptor with the 90-kDa heat shock protein. J Biol Chem 1988, 263:13802-13805.
32. Carver LA, LaPres JJ, Jain S, Dunham EE, Bradfield CA: Characterization of the Ah receptor- associated protein, ARA9. Journal of Biological Chemistry 1998, 273:33580-33587.
33. Meyer BK, Pray-Grant MG, Vanden Heuvel JP, Perdew GH: Hepatitis B virus X-associated protein 2 is a subunit of the unliganded aryl hydrocarbon receptor core complex and exhibits transcriptional enhancer activity. Mol Cell Biol 1998, 18:978-988.
34. Kazlauskas A, Poellinger L, Pongratz I: Evidence that the co-chaperone p23 regulates ligand responsiveness of the dioxin (Aryl hydrocarbon) receptor. J Biol Chem 1999, 274:13519- 13524.
35. Bell DR, Poland A: Binding of aryl hydrocarbon receptor (AhR) to AhR-interacting protein. The role of hsp90. J Biol Chem 2000, 275:36407-36414.
36. Petrulis JR, Hord NG, Perdew GH: Subcellular localization of the aryl hydrocarbon receptor is modulated by the immunophilin homolog hepatitis B virus X-associated protein 2. J Biol Chem 2000, 275:37448-37453.
37. Mimura J, Ema M, Sogawa K, Fujii-Kuriyama Y: Identification of a novel mechanism of regulation of Ah (dioxin) receptor function. Genes Dev 1999, 13:20-25.
38. Oshima M, Mimura J, Yamamoto M, Fujii-Kuriyama Y: Molecular mechanism of transcriptional repression of AhR repressor involving ANKRA2, HDAC4, and HDAC5. Biochem Biophys Res Commun 2007, 364:276-282.
39. Oshima M, Mimura J, Sekine H, Okawa H, Fujii-Kuriyama Y: SUMO modification regulates the transcriptional repressor function of aryl hydrocarbon receptor repressor. J Biol Chem 2009, 284:11017-11026.
40. Gu YZ, Hogenesch JB, Bradfield CA: The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000, 40:519-561.
41. Kewley RJ, Whitelaw ML, Chapman-Smith A: The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol 2004, 36:189-204.
42. Wu D, Rastinejad F: Structural characterization of mammalian bHLH-PAS transcription factors. Curr Opin Struct Biol 2017, 43:1-9.
43. Fukunaga BN, Probst MR, Reiszporszasz S, Hankinson O: IDENTIFICATION OF FUNCTIONAL DOMAINS OF THE ARYL-HYDROCARBON RECEPTOR. Journal of Biological Chemistry 1995, 270:29270-29278.
44. Huang N, Chelliah Y, Shan Y, Taylor CA, Yoo SH, Partch C, Green CB, Zhang H, Takahashi JS: Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex. Science 2012, 337:189-194.
45. Wu D, Potluri N, Lu J, Kim Y, Rastinejad F: Structural integration in hypoxia-inducible factors. Nature 2015, 524:303-308.
46. Wu D, Su X, Potluri N, Kim Y, Rastinejad F: NPAS1-ARNT and NPAS3-ARNT crystal structures implicate the bHLH-PAS family as multi-ligand binding transcription factors. Elife 2016, 5.
47. Seok SH, Lee W, Jiang L, Molugu K, Zheng A, Li Y, Park S, Bradfield CA, Xing Y: Structural hierarchy controlling dimerization and target DNA recognition in the AHR transcriptional complex. Proc Natl Acad Sci U S A 2017, 114:5431-5436.
48. Schulte KW, Green E, Wilz A, Platten M, Daumke O: Structural Basis for Aryl Hydrocarbon Receptor-Mediated Gene Activation. Structure 2017, 25:1025-1033.e1023.
49. Walker MK, Heid SE, Smith SM, Swanson HI: Molecular characterization and developmental expression of the aryl hydrocarbon receptor from the chick embryo. Comp Biochem Physiol C Toxicol Pharmacol 2000, 126:305-319.
50. Eguchi H, Ikuta T, Tachibana T, Yoneda Y, Kawajiri K: A nuclear localization signal of human aryl hydrocarbon receptor nuclear translocator/hypoxia-inducible factor 1beta is a novel bipartite type recognized by the two components of nuclear pore-targeting complex. J Biol Chem 1997, 272:17640-17647.
51. Ikuta T, Eguchi H, Tachibana T, Yoneda Y, Kawajiri K: Nuclear localization and export signals of the human aryl hydrocarbon receptor. J Biol Chem 1998, 273:2895-2904.
52. Kanno Y, Miyama Y, Takane Y, Nakahama T, Inouye Y: Identification of intracellular localization signals and of mechanisms underlining the nucleocytoplasmic shuttling of human aryl hydrocarbon receptor repressor. Biochem Biophys Res Commun 2007, 364:1026-1031.
53. Petrulis JR, Kusnadi A, Ramadoss P, Hollingshead B, Perdew GH: The hsp90 Co-chaperone XAP2 alters importin beta recognition of the bipartite nuclear localization signal of the Ah receptor and represses transcriptional activity. J Biol Chem 2003, 278:2677-2685.
54. Evans BR, Karchner SI, Allan LL, Pollenz RS, Tanguay RL, Jenny MJ, Sherr DH, Hahn ME: Repression of aryl hydrocarbon receptor (AHR) signaling by AHR repressor: role of DNA binding and competition for AHR nuclear translocator. Mol Pharmacol 2008, 73:387-398.
55. Kikuchi Y, Ohsawa S, Mimura J, Ema M, Takasaki C, Sogawa K, Fujii-Kuriyama Y: Heterodimers of bHLH-PAS protein fragments derived from AhR, AhRR, and Arnt prepared by co-expression in Escherichia coli: characterization of their DNA binding activity and preparation of a DNA complex. J Biochem 2003, 134:83-90.
56. Mizushima S, Nagata S: pEF-BOS, a powerful mammalian expression vector. Nucleic Acids Res 1990, 18:5322.
57. Goldenzweig A, Goldsmith M, Hill SE, Gertman O, Laurino P, Ashani Y, Dym O, Unger T, Albeck S, Prilusky J, et al.: Automated Structure- and Sequence-Based Design of Proteins for High Bacterial Expression and Stability. Mol Cell 2016, 63:337-346.
58. Kato Y, Kaneko MK, Kuno A, Uchiyama N, Amano K, Chiba Y, Hasegawa Y, Hirabayashi J, Narimatsu H, Mishima K, et al.: Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain. Biochem Biophys Res Commun 2006, 349:1301-1307.
59. Fujii Y, Kaneko M, Neyazaki M, Nogi T, Kato Y, Takagi J: PA tag: a versatile protein tagging system using a super high affinity antibody against a dodecapeptide derived from human podoplanin. Protein Expr Purif 2014, 95:240-247.
60. Fujii Y, Matsunaga Y, Arimori T, Kitago Y, Ogasawara S, Kaneko MK, Kato Y, Takagi J: Tailored placement of a turn-forming PA tag into the structured domain of a protein to probe its conformational state. J Cell Sci 2016, 129:1512-1522.
61. Arimori T, Kitago Y, Umitsu M, Fujii Y, Asaki R, Tamura-Kawakami K, Takagi J: Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability. Structure 2017, 25:1611-1622.e1614.
62. Ota T, Suzuki Y, Nishikawa T, Otsuki T, Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al.: Complete sequencing and characterization of 21,243 full-length human cDNAs. Nat Genet 2004, 36:40-45.
63. Otsuki T, Ota T, Nishikawa T, Hayashi K, Suzuki Y, Yamamoto J, Wakamatsu A, Kimura K, Sakamoto K, Hatano N, et al.: Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries. DNA Res 2005, 12:117-126.
64. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, Yamashita R, Yamamoto J, Sekine M, Tsuritani K, Wakaguri H, et al.: Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 2006, 16:55-65.
65. Itoh M, Yasunishi A, Imamura K, Kanamori-Katayama M, Suzuki H, Suzuki M, Carninci P, Kawai J, Hayashizaki Y: Constructing ORFeome resources with removable termination codons. Biotechniques 2006, 41:44, 46, 48 passim.
66. Fiser A, Sali A: Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol 2003, 374:461-491.
67. Liu L, Botos I, Wang Y, Leonard JN, Shiloach J, Segal DM, Davies DR: Structural basis of toll- like receptor 3 signaling with double-stranded RNA. Science 2008, 320:379-381.
68. Zivanov J, Nakane T, Forsberg BO, Kimanius D, Hagen WJ, Lindahl E, Scheres SH: New tools for automated high-resolution cryo-EM structure determination in RELION-3. Elife 2018, 7.
69. Grant T, Rohou A, Grigorieff N: cisTEM, user-friendly software for single-particle image processing. Elife 2018, 7.
70. Otwinowski Z, Minor W: [20] Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997, 276:307-326.
71. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ: Phaser crystallographic software. J Appl Crystallogr 2007, 40:658-674.
72. Emsley P, Cowtan K: Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 2004, 60:2126-2132.
73. Murshudov GN, Vagin AA, Dodson EJ: Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr 1997, 53:240-255.
74. Chen VB, Arendall WB, 3rd, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, Richardson DC: MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010, 66:12-21.
75. Shimizu N, Yatabe K, Nagatani Y, Saijyo S, Kosuge T, Igarashi N: Software development for analysis of small-angle x-ray scattering data. 2016: AIP Publishing: 2016:050017.
76. Petoukhov MV, Franke D, Shkumatov AV, Tria G, Kikhney AG, Gajda M, Gorba C, Mertens HD, Konarev PV, Svergun DI: New developments in the ATSAS program package for small-angle scattering data analysis. J Appl Crystallogr 2012, 45:342-350.
77. Svergun DI: Restoring low resolution structure of biological macromolecules from solution scattering using simulated annealing. Biophysical journal 1999, 76:2879-2886.
78. Volkov VV, Svergun DI: Uniqueness of ab initio shape determination in small-angle scattering. Journal of applied crystallography 2003, 36:860-864.
79. Svergun D, Barberato C, Koch MHJ: CRYSOL–a program to evaluate X‐ray solution scattering of biological macromolecules from atomic coordinates. Journal of applied crystallography 1995, 28:768-773.
80. Sakurai S, Shimizu T, Ohto U: The crystal structure of the AhRR-ARNT heterodimer reveals the structural basis of the repression of AhR-mediated transcription. Journal of Biological Chemistry 2017, 292:17609-17616.
81. Tojo M, Matsuzaki K, Minami T, Honda Y, Yasuda H, Chiba T, Saya H, Fujii-Kuriyama Y, Nakao M: The aryl hydrocarbon receptor nuclear transporter is modulated by the SUMO- 1 conjugation system. J Biol Chem 2002, 277:46576-46585.